Included with registration, selections made during registration process (non-cme events).
INDUSTRY BREAKFAST SYMPOSIA
WEDNESDAY MORNING, March 13, 7:00am-8:00am (non-CME)
S1 – Waking up to Endotoxemic Septic Shock. What to You Need to be Ready?
Moderators: John Kellum and Debra Foster
Sponsored by: Spectral Medical
INDUSTRY LUNCH SYMPOSIA
WEDNESDAY AFTERNOON, March 13, 12:30PM-2:00pm (non-CME)
I1 – Renal Replacement Therapy Choices: What are the links to long term outcomes?
Advancements in Acute Kidney Injury drive us to seek a deeper understanding of the choices we make
and their impact on long-term outcomes. Delve into discussions on renal replacement therapy
nomenclature, the intricacies of membrane technology and the critical examination of how modality
choice may impact long-term renal recovery. Join us as we decipher these complexities and uncover the
links that shape the future of Critical Care Nephrology. (speakers TBD)
Nomenclature: What’s in a name? Aren’t they all the same?
Membranes: What is the difference? What difference do they make?
Modality and Renal Recovery: Is there a link?
Sponsored by: Baxter
I2 – New Therapies in Pediatric Acute Kidney Injury
Despite advancements in kidney replacement therapy, little improvement in morbidity and mortality
rates of acute kidney injury (AKI) or sepsis-associated AKI (SA-AKI) have occurred over the past few
decades. Mortality rates in children with AKI and multi-organ failure requiring continuous kidney
replacement therapy (CKRT) continues to remain at ~50%. Additionally, children who survive an AKI
episode are at increased risk of chronic kidney disease (CKD). This program will explore the
background and clinical data supporting the recent humanitarian device exemption (HDE) approval of
the selective cytopheretic device in pediatric AKI due to sepsis or septic conditions requiring CKRT.
Moderator: Stuart Goldstein
Speakers: Ayse Akcan-Arikan, Rajit Basu, David Askenazi
Sponsored by: SeaStar Medical
THURSDAY AFTERNOON, March 14, 12:30pm-2:00pm (non-CME)
I3 – Monitoring ECLS in the ICU PatientModerator: David Thompson
Speakers: Lenar Yessayan and Balazs Szamosfalvi
Sponsored by: Fresenius